CDRH And Industry Scrutinize The Value Of User-Filed Medical Device Reports
This article was originally published in The Gray Sheet
As CDRH reforms its postmarket surveillance systems, it will rely less on "passive" methods of surveillance, such as traditional user-initiated medical device reports (MDRs), and more on "active" systems, such as MedSun reporting and patient registries
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.